Cargando…

Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China

BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tingting, Sun, Li, Xu, Li, Zhao, Ting, Feng, Jie, Yu, Luhai, Wu, Jianhua, Li, Hongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466639/
https://www.ncbi.nlm.nih.gov/pubmed/34563206
http://dx.doi.org/10.1186/s12944-021-01544-3
_version_ 1784573193101508608
author Wang, Tingting
Sun, Li
Xu, Li
Zhao, Ting
Feng, Jie
Yu, Luhai
Wu, Jianhua
Li, Hongjian
author_facet Wang, Tingting
Sun, Li
Xu, Li
Zhao, Ting
Feng, Jie
Yu, Luhai
Wu, Jianhua
Li, Hongjian
author_sort Wang, Tingting
collection PubMed
description BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in minority groups with CHD. OBJECTIVE: To measure levels of lipid and apolipoprotein and the prevalence of dyslipidemia and gene polymorphisms of ABCB1, SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with CHD in Xinjiang. METHODS: This descriptive retrospective study compares lipid levels in ethnic groups using Kruskal-Wallis test or analysis of variance. The study compared gene polymorphisms and the prevalence of dyslipidemia among different ethnic groups using the chi-square test. The lipid profiles in plasma were measured before lipid-lowering therapy using commercially available kits. Genotyping of SLCO1B1 and ABCB1 variants was performed using sequencing by hybridization. RESULTS: A total of 2218 patients were successfully screened, including 1044 Han, 828 Uygur, 113 Kazak, 138 Hui, 39 Tatar, 36 Kirgiz, and 20 Sibe patients. The overall mean age was 61.8 ± 10.8 years, and 72.5% of participants were male. Dyslipidemia prevalence in these ethnic groups was 42.1, 49.8, 52.2, 40.6, 48.7, 41.7, and 45.0%, respectively. The prevalence of dyslipidemia, high total cholesterol (TC), high triglycerides (TG), and high low density lipoprotein cholesterol (LDL-C) differed significantly among the groups (P = 0.024; P < 0.001; P < 0.001; P < 0.001, respectively). For the Han group, high LDL-C, high TC, and high TG prevalence differed significantly by gender (P = 0.001, P = 0.022, P = 0.037, respectively). The prevalence of high TC, high TG, and low high density lipoprotein cholesterol (HDL-C) differed significantly by gender in the Uygur group (P = 0.006, P = 0.004, P < 0.001, respectively). The prevalence of high TC in Hui patients significantly differed by gender (P = 0.043). These findings suggest that polymorphisms in ABCB1 and C3435T differ significantly across ethnicities (P < 0.001). CONCLUSIONS: The prevalences of dyslipidemia, high TC, high TG, and high LDL-C in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe CHD patients in Xinjiang differed concerning ethnicity. Ethnic, gender, and lifestyle were the key factors that affected the lipid levels of the population. The prevalence of polymorphisms of ABCB1 and C3435T significantly differed across ethnicities. These findings will aid the selection of precision lipid-lowering medications and prevention and treatment of CHD according to ethnicity in Xinjiang. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01544-3.
format Online
Article
Text
id pubmed-8466639
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84666392021-09-27 Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China Wang, Tingting Sun, Li Xu, Li Zhao, Ting Feng, Jie Yu, Luhai Wu, Jianhua Li, Hongjian Lipids Health Dis Research BACKGROUND: Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic area; however, little is known about the prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in minority groups with CHD. OBJECTIVE: To measure levels of lipid and apolipoprotein and the prevalence of dyslipidemia and gene polymorphisms of ABCB1, SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with CHD in Xinjiang. METHODS: This descriptive retrospective study compares lipid levels in ethnic groups using Kruskal-Wallis test or analysis of variance. The study compared gene polymorphisms and the prevalence of dyslipidemia among different ethnic groups using the chi-square test. The lipid profiles in plasma were measured before lipid-lowering therapy using commercially available kits. Genotyping of SLCO1B1 and ABCB1 variants was performed using sequencing by hybridization. RESULTS: A total of 2218 patients were successfully screened, including 1044 Han, 828 Uygur, 113 Kazak, 138 Hui, 39 Tatar, 36 Kirgiz, and 20 Sibe patients. The overall mean age was 61.8 ± 10.8 years, and 72.5% of participants were male. Dyslipidemia prevalence in these ethnic groups was 42.1, 49.8, 52.2, 40.6, 48.7, 41.7, and 45.0%, respectively. The prevalence of dyslipidemia, high total cholesterol (TC), high triglycerides (TG), and high low density lipoprotein cholesterol (LDL-C) differed significantly among the groups (P = 0.024; P < 0.001; P < 0.001; P < 0.001, respectively). For the Han group, high LDL-C, high TC, and high TG prevalence differed significantly by gender (P = 0.001, P = 0.022, P = 0.037, respectively). The prevalence of high TC, high TG, and low high density lipoprotein cholesterol (HDL-C) differed significantly by gender in the Uygur group (P = 0.006, P = 0.004, P < 0.001, respectively). The prevalence of high TC in Hui patients significantly differed by gender (P = 0.043). These findings suggest that polymorphisms in ABCB1 and C3435T differ significantly across ethnicities (P < 0.001). CONCLUSIONS: The prevalences of dyslipidemia, high TC, high TG, and high LDL-C in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe CHD patients in Xinjiang differed concerning ethnicity. Ethnic, gender, and lifestyle were the key factors that affected the lipid levels of the population. The prevalence of polymorphisms of ABCB1 and C3435T significantly differed across ethnicities. These findings will aid the selection of precision lipid-lowering medications and prevention and treatment of CHD according to ethnicity in Xinjiang. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01544-3. BioMed Central 2021-09-25 /pmc/articles/PMC8466639/ /pubmed/34563206 http://dx.doi.org/10.1186/s12944-021-01544-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Tingting
Sun, Li
Xu, Li
Zhao, Ting
Feng, Jie
Yu, Luhai
Wu, Jianhua
Li, Hongjian
Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title_full Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title_fullStr Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title_full_unstemmed Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title_short Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China
title_sort prevalence of dyslipidemia and gene polymorphisms of abcb1 and slco1b1 in han, uygur, kazak, hui, tatar, kirgiz, and sibe populations with coronary heart disease in xinjiang, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466639/
https://www.ncbi.nlm.nih.gov/pubmed/34563206
http://dx.doi.org/10.1186/s12944-021-01544-3
work_keys_str_mv AT wangtingting prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT sunli prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT xuli prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT zhaoting prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT fengjie prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT yuluhai prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT wujianhua prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina
AT lihongjian prevalenceofdyslipidemiaandgenepolymorphismsofabcb1andslco1b1inhanuygurkazakhuitatarkirgizandsibepopulationswithcoronaryheartdiseaseinxinjiangchina